Oliveira JFDS, Branquinho FAPL, Monteiro ARRTN, Portugal MECC, Guimarães AMFS. Laryngeal chondrosarcoma – Ten years of experience.
Braz J Otorhinolaryngol 2014;
80:354-8. [PMID:
25183187 PMCID:
PMC9444598 DOI:
10.1016/j.bjorl.2014.05.004]
[Citation(s) in RCA: 21] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2013] [Accepted: 12/06/2013] [Indexed: 11/22/2022] Open
Abstract
Introduction
Laryngeal involvement by cartilaginous tumors is rare. However, although accounting for only 1% of laryngeal tumor pathology, they are the most frequently occurring non-epithelial neoplasms. The most probable location is the endolaryngeal surface of the cricoid cartilage. Their symptoms are variable, depending on the size and location, and may include hoarseness, stridor, and dyspnea. Treatment is based on surgical excision. Some centers take into account the degree of differentiation and whether it is a case of relapse when deciding to perform a radical resection.
Aim
To evaluate this disease in a sample of the Portuguese population.
Methods
A review of the medical records from 2002 to 2012 by assessment of clinical processes was performed. Data on demographics, clinical treatments, and outcomes were collected.
Results
Six patients were included in the study. Five of them underwent total laryngectomy, and in one case, partial excision of the thyroid cartilage was performed. None of the patients had either metastases or tumor-related death.
Conclusion
Laryngeal chondrosarcomas remain a rare disease of unknown etiology, with slow and insidious symptoms. The treatment is surgical, with favorable prognosis, and metastases rarely occur. The main concern regards their propensity to relapse.
Collapse